BioTechGrid – Page 327

‘It’s making a difference’: Madrigal CEO talks strategy behind MASH shopping spree

July 31, 2026

Not content with navigating Rezdiffra’s trajectory to blockbuster territory, Madrigal Pharmaceuticals has spent 2026 shopping for a range of drugs…

Biotechnology

Novo Nordisk left praying to Artemis and Hermes to salvage CKD program after phase 3 fail

July 31, 2026

A phase 3 trial of Novo Nordisk’s ziltivekimab has missed its primary endpoint, denting the prospects of a molecule analysts…

Biotechnology

Apnimed’s IPO dream comes true with upsized $192M IPO to fund sleep apnea pill launch

July 31, 2026

Apnimed has raised $192 million for its upsized IPO, with the proceeds earmarked to fund the launch of its sleep…

Genetics

Spatiotemporal Multiomics Charts Cellular Dynamics of Liver Metastasis

July 30, 2026

Credit: rightdx/ iStock / Getty Images Plus Metastasis remains one of cancer’s most difficult biological transitions to capture: tumor cells…

Genetics

A Computational Framework for Designing Disordered Proteins at Large Scale

July 30, 2026

Credit: Christoph Burgstedt/Getty Images The vast majority of proteins in our bodies contain regions that are in a constant state…

Genetics

Mitochondrial–Epigenetic Pathway Linked to Age-Related Inflammation

July 30, 2026

Credit: KATERYNA KON / Getty Images / Science Photo Library Scientists have identified a mechanism that helps aging cells drive…

Biotechnology

Replimune’s twice-rejected melanoma drug prevails in FDA adcomm

July 30, 2026

Following a pair of FDA rejections of its melanoma drug, Replimune’s fortunes flipped today after an advisory committee voted 10…

Biotechnology

Chutes & Ladders—Legend CEO departs without successor in place

July 30, 2026

Legend Biotech CEO Ying Huang, Ph.D., has left the company suddenly, without a predecessor in place. Huang was elevated from…

Biotechnology

Cemiplimab and fianlimab with neoadjuvant chemotherapy in early-stage high-risk -negative breast cancer

July 30, 2026

About the Study: Is combined inhibition of programmed cell death 1 protein (PD-1) and lymphocyte activation gene 3 (LAG-3) added…

Biotechnology

Combined phage therapy and faecal microbiota transplantation to treat recurrent urinary tract infection: a case series

July 30, 2026

McCallin, S., Classen, A.Y., Lieberknecht-Jouy, S.C. et al. Combined phage therapy and faecal microbiota transplantation to treat recurrent urinary tract…

Lightweight AI Reads Brain Tumor Scans and Knows When It Is Unsure

Blood Type Offers No Shield Against Common Skin Warts, Study Finds

New AI Framework Blends Infrared and Visible Images by Seeing Others and Focusing Itself

Sick Leeches Keep Their Microbial Diversity but Lose Their Microbial Stability

Brain Tumor Biomarker Survives Tough Test: MGMT Signal Holds After Batch Effect Scrutiny

UTHealth Houston Scientist Wins $12 Million to Probe Brain Energy and Aging

Exploring the Future of Healthcare with Panos Karelis

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

‘It’s making a difference’: Madrigal CEO talks strategy behind MASH shopping spree

Novo Nordisk left praying to Artemis and Hermes to salvage CKD program after phase 3 fail

Apnimed’s IPO dream comes true with upsized $192M IPO to fund sleep apnea pill launch

Spatiotemporal Multiomics Charts Cellular Dynamics of Liver Metastasis

A Computational Framework for Designing Disordered Proteins at Large Scale

Mitochondrial–Epigenetic Pathway Linked to Age-Related Inflammation

Replimune’s twice-rejected melanoma drug prevails in FDA adcomm

Chutes & Ladders—Legend CEO departs without successor in place

Cemiplimab and fianlimab with neoadjuvant chemotherapy in early-stage high-risk -negative breast cancer

Combined phage therapy and faecal microbiota transplantation to treat recurrent urinary tract infection: a case series

VertigoDx on firm ground with FDA greenlight for vertigo diagnostic system

Precision Neuroscience taps $250M in Series D funding for brain-computer interface

VC Sofinnova reels in €82M to target medtechs in the next 5 years

Adagio Medical kicks off strategic review, trims more than half its staff